Valence Discovery Website, Blog & Press Pages

Valence Discovery Website, Blog & Press Pages - aVenture

Valence Discovery - Library

valencelabs.comCrawled Oct 16, 2026

Blog

7 pages

Advancing Drug Discovery Outcomes with Virtual Cells at Recursion/advancing-drug-discovery-outcomes-with-virtual-cells-at-recursion
The company frames its view of the virtual cell around three interconnected capabilities.
Introducing MolGPS — A Foundational GNN for Molecular Property Prediction/introducing-molgps-a-foundational-gnn-for-molecular-property-prediction
The page says scaling deep learning models has been at the heart of recent revolutions in language modeling and image generation.
Introducing OpenQDC - The Open-Source Hub of ML-Ready Quantum Datasets/introducing-openqdc-the-open-source-hub-of-ml-ready-quantum-datasets
The company curated and consolidated more than 40 quantum mechanics (QM) datasets covering 1.5 billion geometries across 70 atom species and more than 250 QM methods.
LOWE. An LLM-orchestrated Workflow Engine unleashing the full power of Recursion’s data and tools/lowe-an-llm-orchestrated-workflow-engine-unleashing-the-full-power-of-recursions-data-and-tools
LOWE (LLM-orchestrated Workflow Engine) is an LLM agent.

Press

1 page

Blog/announcements
Valence Labs produces groundbreaking research at the intersection of AI and drug discovery with a steadfast commitment to improving drug discovery outcomes.

Careers & Hiring

2 pages

Careers/careers
Valence Labs has open opportunities in drug discovery.
Work with us/careers
Valence Labs invites people to build the future of drug discovery and lists open opportunities.

Homepage

2 pages

Homepage/
Valence Labs, powered by Recursion, is an AI research engine accelerating Recursion’s mission of decoding biology to radically improve lives.
Homepage/
Valence Labs, powered by Recursion, is an AI research engine accelerating Recursion’s mission of decoding biology to radically improve lives.

Privacy

2 pages

Privacy policy/privacy-policy
Valence Discovery Inc.'s privacy policy, also referred to as Valence Labs, was last updated July 23, 2025.
Privacy policy/privacy-policy
Valence Discovery Inc., also known as Valence Labs, describes its privacy practices in a policy last updated July 23rd, 2025.

Coverage

8 items

Nvidia invests $50 million in Recursion for drug discoverybetakit.com/after-buying-cyclica-and-valence-recursion-secures-50-million-usd-from-nvidia-for-ai-drug-discovery/
Nvidia invests $50 million in Recursion to fuel development of Recursion’s AI technology for drug discovery. The deal also includes a collaboration between the two US firms.
Jul 2023 · BetaKitNews article
Recursion boosts drug discovery with Cyclica and Valence acquisitionslabiotech.eu/trends-news/recursion-acquires-cyclica-valence/
Recursion signs agreements to acquire Cyclica and Valence, two companies in the AI-enabled drug discovery space.
May 2023 · Labiotech.euNews article
Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilitiesfinancialpost.com/globe-newswire/recursion-enters-into-agreements-to-acquire-cyclica-and-valence-to-bolster-chemistry-and-generative-ai-capabilities
Recursion announces it has signed agreements to acquire AI-enabled drug discovery companies Cyclica and Valence. The announcement lists Cyclica at $40 million and Valence at $47.5 million, says both will be integrated into RecursionOS, and describes the deals as bolstering Recursion’s chemistry and generative AI capabilities.
May 2023 · financialpostNews article
Valence Discovery Grows Leadership Team with Key Drug Discovery Hireslelezard.com/en/news-valence-discovery-grows-leadership-team-with-key-drug-discovery-hires-20592785.html
Valence Discovery announces additions to its leadership team through key drug discovery hires. The article does not identify the hires in the provided text.
Oct 2022 · lelezard.comNews article